Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study
Not Applicable
- Conditions
- Type2 Diabetes
- Registration Number
- JPRN-UMIN000001110
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Type 1 diabetes (2)Those who have used different medication for diabetes from metformin-alone (including insulin) period,or have changed the diet therapy and exercise therapy during run-in period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in HbA1C at the end of the treatment period
- Secondary Outcome Measures
Name Time Method